These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 28225684)

  • 1. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator.
    Russo RJ; Costa HS; Silva PD; Anderson JL; Arshad A; Biederman RW; Boyle NG; Frabizzio JV; Birgersdotter-Green U; Higgins SL; Lampert R; Machado CE; Martin ET; Rivard AL; Rubenstein JC; Schaerf RH; Schwartz JD; Shah DJ; Tomassoni GF; Tominaga GT; Tonkin AE; Uretsky S; Wolff SD
    N Engl J Med; 2017 Feb; 376(8):755-764. PubMed ID: 28225684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry.
    Russo RJ
    Am Heart J; 2013 Mar; 165(3):266-72. PubMed ID: 23453091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices.
    Nazarian S; Hansford R; Rahsepar AA; Weltin V; McVeigh D; Gucuk Ipek E; Kwan A; Berger RD; Calkins H; Lardo AC; Kraut MA; Kamel IR; Zimmerman SL; Halperin HR
    N Engl J Med; 2017 Dec; 377(26):2555-2564. PubMed ID: 29281579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.
    Cohen JD; Costa HS; Russo RJ
    Am J Cardiol; 2012 Dec; 110(11):1631-6. PubMed ID: 22921995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe.
    Mason S; Osborn JS; Dhar R; Tonkin A; Ethington JD; Le V; Benuzillo J; Lappe DL; Knowlton KU; Bunch TJ; Anderson JL
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1468-1474. PubMed ID: 28960745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical safety of an MRI conditional implantable cardioverter defibrillator system: A prospective Monocenter ICD-Magnetic resonance Imaging feasibility study (MIMI).
    Kypta A; Blessberger H; Hoenig S; Saleh K; Lambert T; Kammler J; Fellner F; Lichtenauer M; Steinwender C
    J Magn Reson Imaging; 2016 Mar; 43(3):574-84. PubMed ID: 26335332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI).
    Burke PT; Ghanbari H; Alexander PB; Shaw MK; Daccarett M; Machado C
    J Interv Card Electrophysiol; 2010 Jun; 28(1):59-66. PubMed ID: 20111895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3 Tesla magnetic resonance imaging in patients with cardiac implantable electronic devices: a single centre experience.
    Fluschnik N; Tahir E; Erley J; Müllerleile K; Metzner A; Wenzel JP; Guerreiro H; Adam G; Blankenberg S; Kirchhof P; Tönnis T; Nikorowitsch J
    Europace; 2023 Feb; 25(2):571-577. PubMed ID: 36413601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficiency of low-field magnetic resonance imaging in patients with cardiac rhythm management devices.
    Schukro C; Puchner SB
    Eur J Radiol; 2019 Sep; 118():96-100. PubMed ID: 31439265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Performance of Magnetic Resonance Imaging Conditional and Nonconditional Cardiac Implantable Electronic Devices.
    Shah AD; Patel AU; Knezevic A; Hoskins MH; Hirsh DS; Merchant FM; El Chami MF; Delurgio DB; Patel AM; Leon AR; Langberg JJ; Lloyd MS
    Pacing Clin Electrophysiol; 2017 May; 40(5):467-475. PubMed ID: 28224629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Safety of Cardiac and Thoracic Magnetic Resonance Imaging in Patients with Cardiac Implantable Electronic Devices.
    Dandamudi S; Collins JD; Carr JC; Mongkolwat P; Rahsepar AA; Tomson TT; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Acad Radiol; 2016 Dec; 23(12):1498-1505. PubMed ID: 27717762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and outcomes of magnetic resonance imaging in patients with abandoned pacemaker and defibrillator leads.
    Higgins JV; Gard JJ; Sheldon SH; Espinosa RE; Wood CP; Felmlee JP; Cha YM; Asirvatham SJ; Dalzell C; Acker N; Watson RE; Friedman PA
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1284-90. PubMed ID: 24809591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators.
    Naehle CP; Strach K; Thomas D; Meyer C; Linhart M; Bitaraf S; Litt H; Schwab JO; Schild H; Sommer T
    J Am Coll Cardiol; 2009 Aug; 54(6):549-55. PubMed ID: 19643318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety of magnetic resonance imaging in patients with pacemaker and implantable defibrillator].
    Al-Sabagh KH; Christensen BE; Thøgersen AM; Petersen HH; Videbaek R; Pehrson S; Chen X; Thomsen C; Svendsen JH
    Ugeskr Laeger; 2010 Jun; 172(23):1740-4. PubMed ID: 20534201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads.
    Sheldon SH; Bunch TJ; Cogert GA; Acker NG; Dalzell CM; Higgins JV; Espinosa RE; Asirvatham SJ; Cha YM; Felmlee JP; Watson RE; Anderson JL; Brooks MH; Osborn JS; Friedman PA
    Heart Rhythm; 2015 Feb; 12(2):345-9. PubMed ID: 25433144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable Defibrillator System Shock Function, Mortality, and Cause of Death After Magnetic Resonance Imaging.
    Ra J; Oberdier MT; Suzuki M; Vaidya D; Liu Y; Hansford R; McVeigh D; Weltin V; Tao S; Thiemann DR; Nazarian S; Halperin HR
    Ann Intern Med; 2023 Mar; 176(3):289-297. PubMed ID: 36716451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracic versus nonthoracic MR imaging for patients with an MR nonconditional cardiac implantable electronic device.
    Nyotowidjojo IS; Skinner K; Shah AS; Bisla J; Singh S; Khoubyari R; Ott P; Kalb B; Indik JH
    Pacing Clin Electrophysiol; 2018 Jun; 41(6):589-596. PubMed ID: 29603272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical safety of the Iforia implantable cardioverter-defibrillator system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions.
    Awad K; Griffin J; Crawford TC; Lane Cox S; Ferrick K; Mazur A; Pena RE; Lloyd SG; Michalski J; Johnson W; Bailey WM
    Heart Rhythm; 2015 Oct; 12(10):2155-61. PubMed ID: 26049048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of magnetic resonance imaging in patients with cardiac implantable electronic devices with generator and lead(s) brand mismatch.
    Minaskeian N; Hajnal SP; Liu MB; Klooster LM; Devick KL; Schwartz L; Jokerst CE; Sorajja D; Scott LR
    J Appl Clin Med Phys; 2022 Mar; 23(3):e13520. PubMed ID: 35066975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
    J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.